The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Personalized Mapping of Drug Metabolism by the Human Gut Microbiome
Open accessAbstract
Summary The human gut microbiome harbors hundreds of bacterial species with diverse biochemical capabilities. Dozens of drugs have been shown to be metabolized by single isolates from the gut microbiome, but the extent of this phenomenon is rarely explored in the context of microbial communities. Here, we develop a quantitative experimental framework for mapping the ability of the human gut microbiome to metabolize small molecule drugs: Microbiome Derived Metabolism (MDM)-Screen. Included are a batch culturing system for sustained growth of subject-specific gut microbial communities, an ex vivo drug metabolism screen, and targeted and untargeted functional metagenomic screens to identify microbiome-encoded genes responsible for specific metabolic events. Our framework identifies novel drug-microbiome interactions that vary between individuals and demonstrates how the gut microbiome might be used in drug development and personalized medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400 · cited 2×
“do not map to the backbone were then aligned to the SPAdes scaffolds produced from the PD metagenomic dataset, also using Bowtie2 (--very-sensitive-local) (Langmead and Salzberg, 2012).”
BackgroundMethodCytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Matplotlib: a 2D graphics environment
Hunter, J. D. (2007) · Computing in Science & Engineering · doi:10.1109/mcse.2007.55 · Cited by 39,249
DADA2: High–resolution sample inference from Illumina amplicon data
Callahan, B. J., McMurdie, P. J., Rosen, M. J., Han, A. W., Johnson, A. J. A., & Holmes, S. P. (2016) · Nature Methods · doi:10.1038/nmeth.3869 · Cited by 35,698
SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing
Bankevich, A., Nurk, S., Antipov, D., Gurevich, A. A., Dvorkin, M., Kulikov, A. S., Lesin, V. M., Nikolenko, S. I., Pham, S., Prjibelski, A. D., et al. (2012) · Journal of Computational Biology · doi:10.1089/cmb.2012.0021 · Cited by 25,987
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
Bolyen, E., Rideout, J. R., Dillon, M. R., Bokulich, N. A., Abnet, C. C., Al-Ghalith, G. A., Alexander, H., Alm, E. J., Arumugam, M., Asnicar, F., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0209-9 · Cited by 23,742
Kearse, M., Moir, R., Wilson, A., Stones-Havas, S., Cheung, M., Sturrock, S., Buxton, S., Cooper, A., Markowitz, S., Duran, C., et al. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts199 · Cited by 20,027
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
Datsenko, K. A., & Wanner, B. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120163297 · Cited by 14,782
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Data Structures for Statistical Computing in Python
McKinney, W. (2010) · Proceedings of the Python in Science Conference · doi:10.25080/majora-92bf1922-00a · Cited by 11,032
Open Babel: An open chemical toolbox
O'Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011) · Journal of Cheminformatics · doi:10.1186/1758-2946-3-33 · Cited by 10,939
Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms
Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Huntley, J., Fierer, N., Owens, S. M., Betley, J., Fraser, L., Bauer, M., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2012.8 · Cited by 8,839
Construction of Escherichia coli K‐12 in‐frame, single‐gene knockout mutants: the Keio collection
Baba, T., Ara, T., Hasegawa, M., Takai, Y., Okumura, Y., Baba, M., Datsenko, K. A., Tomita, M., Wanner, B. L., & Mori, H. (2006) · Molecular Systems Biology · doi:10.1038/msb4100050 · Cited by 7,858
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Bokulich, N. A., Kaehler, B. D., Rideout, J. R., Dillon, M., Bolyen, E., Knight, R., Huttley, G. A., & Gregory Caporaso, J. (2018) · Microbiome · doi:10.1186/s40168-018-0470-z · Cited by 5,881
A Direct Approach to False Discovery Rates
Storey, J. D. (2002) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/1467-9868.00346 · Cited by 5,603
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277 · cited 1×
“This enormous diversity and richness represent a repertoire of yet-uncharacterized biochemical activities capable of metabolizing ingested chemicals (Backhed et al., 2005; Koppel et al., 2017).”
BackgroundQuality control and preprocessing of metagenomic datasets
Schmieder, R., & Edwards, R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr026 · Cited by 5,072
McDonald, D., Price, M. N., Goodrich, J., Nawrocki, E. P., DeSantis, T. Z., Probst, A., Andersen, G. L., Knight, R., & Hugenholtz, P. (2012) · The ISME Journal · doi:10.1038/ismej.2011.139 · Cited by 5,064
Wang, M., Carver, J. J., Phelan, V. V., Sanchez, L. M., Garg, N., Peng, Y., Nguyen, D. D., Watrous, J., Kapono, C. A., Luzzatto-Knaan, T., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3597 · Cited by 4,629
Kraken: ultrafast metagenomic sequence classification using exact alignments
Wood, D. E., & Salzberg, S. L. (2014) · Genome Biology · doi:10.1186/gb-2014-15-3-r46 · Cited by 4,521
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., et al. (2015) · Science · doi:10.1126/science.aac4255 · Cited by 3,888 · cited 1×
“on the immune system in anticancer immunotherapy (Iida et al., 2013; Sivan et al., 2015; Vetizou et al., 2015), microbiome reactivation of secreted inactive metabolites of the drug (Wallace et al.”
BackgroundAnticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Vétizou, M., Pitt, J. M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M. P., Duong, C. P. M., et al. (2015) · Science · doi:10.1126/science.aad1329 · Cited by 3,488 · cited 2×
“…A uthor M anuscript A uthor M anuscript A uthor M anuscript on the immune system in anticancer immunotherapy (Iida et al., 2013; Sivan et al., 2015; Vetizou et al., 2015), microbiome reactivation of secreted inactive metabolites of the drug (Wallace et al., 2010), and overall microbiome effects on…”
BackgroundPopulation-level analysis of gut microbiome variation
Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., Kurilshikov, A., Bonder, M. J., Valles-Colomer, M., Vandeputte, D., et al. (2016) · Science · doi:10.1126/science.aad3503 · Cited by 2,400
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Iida, N., Dzutsev, A., Stewart, C. A., Smith, L., Bouladoux, N., Weingarten, R. A., Molina, D. A., Salcedo, R., Back, T., Cramer, S., et al. (2013) · Science · doi:10.1126/science.1240527 · Cited by 2,251
Extensive impact of non-antibiotic drugs on human gut bacteria
Maier, L., Pruteanu, M., Kuhn, M., Zeller, G., Telzerow, A., Anderson, E. E., Brochado, A. R., Fernandez, K. C., Dose, H., Mori, H., et al. (2018) · Nature · doi:10.1038/nature25979 · Cited by 1,905
Pasolli, E., Asnicar, F., Manara, S., Zolfo, M., Karcher, N., Armanini, F., Beghini, F., Manghi, P., Tett, A., Ghensi, P., et al. (2019) · Cell · doi:10.1016/j.cell.2019.01.001 · Cited by 1,591
A new genomic blueprint of the human gut microbiota
Almeida, A., Mitchell, A. L., Boland, M., Forster, S. C., Gloor, G. B., Tarkowska, A., Lawley, T. D., & Finn, R. D. (2019) · Nature · doi:10.1038/s41586-019-0965-1 · Cited by 1,314
Strains, functions and dynamics in the expanded Human Microbiome Project
Lloyd-Price, J., Mahurkar, A., Rahnavard, G., Crabtree, J., Orvis, J., Hall, A. B., Brady, A., Creasy, H. H., McCracken, C., Giglio, M. G., et al. (2017) · Nature · doi:10.1038/nature23889 · Cited by 1,267
Rondon, M. R., August, P. R., Bettermann, A. D., Brady, S. F., Grossman, T. H., Liles, M. R., Loiacono, K. A., Lynch, B. A., MacNeil, I. A., Minor, C., et al. (2000) · Applied and Environmental Microbiology · doi:10.1128/aem.66.6.2541-2547.2000 · Cited by 1,241
MetaHIT Consortium, Nielsen, H. B., Almeida, M., Juncker, A. S., Rasmussen, S., Li, J., Sunagawa, S., Plichta, D. R., Gautier, L., Pedersen, A. G., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2939 · Cited by 1,184
Mapping human microbiome drug metabolism by gut bacteria and their genes
Zimmermann, M., Zimmermann-Kogadeeva, M., Wegmann, R., & Goodman, A. L. (2019) · Nature · doi:10.1038/s41586-019-1291-3 · Cited by 1,160
Chemical transformation of xenobiotics by the human gut microbiota
Koppel, N., Maini Rekdal, V., & Balskus, E. P. (2017) · Science · doi:10.1126/science.aag2770 · Cited by 1,080
Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
Wallace, B. D., Wang, H., Lane, K. T., Scott, J. E., Orans, J., Koo, J. S., Venkatesh, M., Jobin, C., Yeh, L.-A., Mani, S., et al. (2010) · Science · doi:10.1126/science.1191175 · Cited by 1,080
American Gut: an Open Platform for Citizen-Science Microbiome Research
McDonalda, D., Hyde, E., Debelius, J. W., Morton, J. T., Gonzalez, A., Ackermann, G., Aksenov, A. A., Behsaz, B., Brennan, C., Chen, Y., et al. (2018) · doi:10.1101/277970 · Cited by 878
Functional characterization of the antibiotic resistance reservoir in the human microflora
Sommer, M. O. A., Dantas, G., & Church, G. M. (2009) · Science · doi:10.1126/science.1176950 · Cited by 878 · cited 1×
“, for antibiotic resistance or an engineered circuit for survival) (Genee et al., 2016; Sommer et al., 2009; Uribe et al., 2019), or a visual readout (e.”
BackgroundClinical Pharmacokinetics of Mycophenolate Mofetil
Bullingham, R. E. S., Nicholls, A. J., & Kamm, B. R. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199834060-00002 · Cited by 839
QIIME 2: Reproducible, interactive, scalable, and extensible microbiome data science
Bolyen, E., Rideout, J. R., Dillon, M. R., Bokulich, N. A., Abnet, C., Al-Ghalith, G. A., Alexander, H., Alm, E. J., Arumugam, M., Asnicar, F., et al. (2018) · doi:10.7287/peerj.preprints.27295v1 · Cited by 838
Goodman, A. L., Kallstrom, G., Faith, J. J., Reyes, A., Moore, A., Dantas, G., & Gordon, J. I. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102938108 · Cited by 777
Clayton, T. A., Baker, D., Lindon, J. C., Everett, J. R., & Nicholson, J. K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904489106 · Cited by 765
Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism
Maini Rekdal, V., Bess, E. N., Bisanz, J. E., Turnbaugh, P. J., & Balskus, E. P. (2019) · Science · doi:10.1126/science.aau6323 · Cited by 753
New insights from uncultivated genomes of the global human gut microbiome
Nayfach, S., Shi, Z. J., Seshadri, R., Pollard, K. S., & Kyrpides, N. C. (2019) · Nature · doi:10.1038/s41586-019-1058-x · Cited by 737 · cited 1×
“A major challenge in studying the capacity of the human gut microbiome to metabolize orally administered drugs is the diversity of bacterial species and strains involved (Almeida et al., 2019; Lloyd-Price et al., 2017; Nayfach et al., 2019; Pasolli et al., 2019; Qin et al., 2010).”
BackgroundThe microbial pharmacists within us: a metagenomic view of xenobiotic metabolism
Spanogiannopoulos, P., Bess, E. N., Carmody, R. N., & Turnbaugh, P. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.17 · Cited by 717
Predicting and Manipulating Cardiac Drug Inactivation by the Human Gut Bacterium Eggerthella lenta
Haiser, H. J., Gootenberg, D. B., Chatman, K., Sirasani, G., Balskus, E. P., & Turnbaugh, P. J. (2013) · Science · doi:10.1126/science.1235872 · Cited by 704 · cited 3×
“, digoxin reduction by Eggerthella lenta) (Haiser et al., 2013).”
BackgroundResultQIIME 2: Reproducible, interactive, scalable, and extensible microbiome data science
Bolyen, E., Rideout, J. R., Dillon, M. R., Bokulich, N. A., Abnet, C., Al-Ghalith, G. A., Alexander, H., Alm, E. J., Arumugam, M., Asnicar, F., et al. (2018) · doi:10.7287/peerj.preprints.27295v2 · Cited by 552
van Kessel, S. P., Frye, A. K., El-Gendy, A. O., Castejon, M., Keshavarzian, A., van Dijk, G., & El Aidy, S. (2019) · Nature Communications · doi:10.1038/s41467-019-08294-y · Cited by 521
Metabolism of Foreign Compounds by Gastrointestinal Microorganisms
Scheline, R. R. (1973) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06622-0 · Cited by 513
Isolation of Antibiotics Turbomycin A and B from a Metagenomic Library of Soil Microbial DNA
Gillespie, D. E., Brady, S. F., Bettermann, A. D., Cianciotto, N. P., Liles, M. R., Rondon, M. R., Clardy, J., Goodman, R. M., & Handelsman, J. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.9.4301-4306.2002 · Cited by 494
THE ROLE OF INTESTINAL BACTERIA IN THE METABOLISM OF SALICYLAZOSULFAPYRIDINE
PEPPERCORN, M. A., & GOLDMAN, P. (1972) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29238-2 · Cited by 450
Separating host and microbiome contributions to drug pharmacokinetics and toxicity
Zimmermann, M., Zimmermann-Kogadeeva, M., Wegmann, R., & Goodman, A. L. (2019) · Science · doi:10.1126/science.aat9931 · Cited by 423
Ridlon, J. M., Ikegawa, S., Alves, J. M. P., Zhou, B., Kobayashi, A., Iida, T., Mitamura, K., Tanabe, G., Serrano, M., De Guzman, A., et al. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m038869 · Cited by 319
Development of the gut microbiota and mucosal IgA responses in twins and gnotobiotic mice
Planer, J. D., Peng, Y., Kau, A. L., Blanton, L. V., Ndao, I. M., Tarr, P. I., Warner, B. B., & Gordon, J. I. (2016) · Nature · doi:10.1038/nature17940 · Cited by 319
Nutritional preferences of human gut bacteria reveal their metabolic idiosyncrasies
Tramontano, M., Andrejev, S., Pruteanu, M., Klünemann, M., Kuhn, M., Galardini, M., Jouhten, P., Zelezniak, A., Zeller, G., Bork, P., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0123-9 · Cited by 295
Mobile genes in the human microbiome are structured from global to individual scales
Brito, I. L., Yilmaz, S., Huang, K., Xu, L., Jupiter, S. D., Jenkins, A. P., Naisilisili, W., Tamminen, M., Smillie, C. S., Wortman, J. R., et al. (2016) · Nature · doi:10.1038/nature18927 · Cited by 288 · cited 5×
“The following datasets were used for the metagenomic analysis of the genes of interest in this study: HMP-1-1 (Human Microbiome Project, 2012), HMP-1-2 (Lloyd-Price et al., 2017), MetaHIT (Nielsen et al., 2014), Chinese (Qin et al., 2012), and Fijicomp (Brito et al., 2016).”
BackgroundMethodInfluentialAbsorption, metabolism, and excretion of risperidone in humans.
Mannens, G., Huang, M. L., Meuldermans, W., Hendrickx, J., Woestenborghs, R., & Heykants, J. (1993) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08211-x · Cited by 261
Northfield, T. C., & McColl, I. (1973) · Gut · doi:10.1136/gut.14.7.513 · Cited by 206
Cohen, L. J., Kang, H.-S., Chu, J., Huang, Y.-H., Gordon, E. A., Reddy, B. V. B., Ternei, M. A., Craig, J. W., & Brady, S. F. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508737112 · Cited by 203
Mebolism of drugs and other xenobiotics in the gut lumen and wall
Ilett, K. F., Tee, L. B. G., Reeves, P. T., & Minchin, R. F. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90036-2 · Cited by 201
Sica, D. A. (2005) · Heart Failure Reviews · doi:10.1007/s10741-005-2345-1 · Cited by 192
Rettedal, E. A., Gumpert, H., & Sommer, M. O. A. (2014) · Nature Communications · doi:10.1038/ncomms5714 · Cited by 169
TAS-102, a novel antitumor agent: A review of the mechanism of action
Lenz, H.-J., Stintzing, S., & Loupakis, F. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.06.001 · Cited by 163
New Natural Product Families from an Environmental DNA (eDNA) Gene Cluster
Brady, S. F., Chao, C. J., & Clardy, J. (2002) · Journal of the American Chemical Society · doi:10.1021/ja0268985 · Cited by 157
A metagenomic strategy for harnessing the chemical repertoire of the human microbiome
Sugimoto, Y., Camacho, F. R., Wang, S., Chankhamjon, P., Odabas, A., Biswas, A. G., Jeffrey, P. D., & Donia, M. S. (2019) · Science · doi:10.1126/science.aax9176 · Cited by 152
Self-citationIn Vitro Metabolism of Tolcapone to Reactive Intermediates: Relevance to Tolcapone Liver Toxicity
Smith, K. S., Smith, P. L., Heady, T. N., Trugman, J. M., Harman, W. D., & Macdonald, T. L. (2003) · Chemical Research in Toxicology · doi:10.1021/tx025569n · Cited by 147
Koppel, N., Bisanz, J. E., Pandelia, M., Turnbaugh, P. J., & Balskus, E. P. (2018) · eLife · doi:10.7554/elife.33953 · Cited by 147
Taylor, M. R., Flannigan, K. L., Rahim, H., Mohamud, A., Lewis, I. A., Hirota, S. A., & Greenway, S. C. (2019) · Science Advances · doi:10.1126/sciadv.aax2358 · Cited by 136
The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man.
Azad-Khan, A., Truelove, S. C., & Aronson, J. (1982) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1982.tb01415.x · Cited by 133
Spironolactone Metabolism: Steady‐State Serum Levels of the Sulfur‐Containing Metabolites
Gardiner, P., Schrode, K. B., Quinlan, D., Martin, B. K., Boreham, D. R., Rogers, M. S., Stubbs, K., Smith, M. E., & Karim, A. (1989) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1989.tb03339.x · Cited by 133
The oral fluoropyrimidines in cancer chemotherapy.
Lamont, E. B., & Schilsky, R. L. (1999) · PubMed · Cited by 113
Meinl, W., Sczesny, S., Brigelius‐Flohé, R., Blaut, M., & Glatt, H. R. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.025916 · Cited by 96
Metabolism and excretion of tolcapone, a novel inhibitor of catechol‐O‐methyltransferase
Jorga, K. M., Fotteler, B., Heizmann, P., & Gasser, R. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00036.x · Cited by 94
Microbiota signalling through MyD88 is necessary for a systemic neutrophilic inflammatory response
Karmarkar, D., & Rock, K. L. (2013) · Immunology · doi:10.1111/imm.12159 · Cited by 94
Cometabolism of Microbes and Host: Implications for Drug Metabolism and Drug-Induced Toxicity
Li, H., & Jia, W. P. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.157 · Cited by 94
Discovery and Characterization of Cas9 Inhibitors Disseminated across Seven Bacterial Phyla
Vazquez-Uribe, R., van der Helm, E., Misiakou, M.-A., Lee, S., Kol, S., & Sommer, M. O. A. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.01.003 · Cited by 79
Functional mining of transporters using synthetic selections
Genee, H. J., Bali, A. P., Petersen, S. D., Siedler, S., Bonde, M., Gronenberg, L. S., Kristensen, M., Harrison, S. J., & Sommer, M. O. A. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2189 · Cited by 76
Urinary excretion of reduced metabolites of digoxin
Lindenbaum, J., Tse-Eng, D., Butler, V. P., & Rund, D. G. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90260-6 · Cited by 73
The metabolism and excretion of risperidone after oral administration in rats and dogs.
Meuldermans, W., Hendrickx, J., Mannens, G., Lavrijsen, K., Janssen, C., Bracke, J., Jeune, L. L., Lauwers, W., & Heykants, J. (1994) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08286-8 · Cited by 73
Role of the intestinal microflora in clonazepam metabolism in the rat
Elmer, G. W., & Remmel, R. P. (1984) · Xenobiotica · doi:10.3109/00498258409151481 · Cited by 64
Devendran, S., Méndez–García, C., & Ridlon, J. M. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m074914 · Cited by 55
Doden, H. L., Pollet, R. M., Mythen, S. M., Wawrzak, Z., Devendran, S., Cann, I., Koropatkin, N. M., & Ridlon, J. M. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009390 · Cited by 44
Formation of 20β-dihydrosteroids by anaerobic bacteria
Winter, J., Cerone-McLernon, A. M., O'Rourke, S., Ponticorvo, L., & Bokkenheuser, V. D. (1982) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(82)90568-4 · Cited by 40
Cleary, J. M., Rosen, L. S., Yoshida, K., Rasco, D. W., Shapiro, G. I., & Sun, W. (2017) · Investigational New Drugs · doi:10.1007/s10637-016-0409-9 · Cited by 37
Sample Size and Power Calculations using the Noncentral t-distribution
Harrison, D. A., & Brady, T. (2004) · The Stata Journal Promoting communications on statistics and Stata · doi:10.1177/1536867x0400400205 · Cited by 32
Tsai, B. S., Kessler, L. K., Stolzenbach, J. C., Schoenhard, G. L., & Bauer, R. F. (1991) · Digestive Diseases and Sciences · doi:10.1007/bf01297024 · Cited by 14
Cited by
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193
Gut microbiota and cardiovascular disease.
Witkowski, M., Weeks, T. L., & Hazen, S. L. (2020) · Circulation Research · doi:10.1161/circresaha.120.316242 · Cited by 1,051
Antibiotic perturbations to the gut microbiome
Fishbein, S. R. S., Mahmud, B., & Dantas, G. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00933-y · Cited by 440
“These extrinsic host influences are not typically accounted for in antibiotic–microbiome investigations, despite the clear capacity of many of these xenobiotic compounds to affect growth promotion or inhibition in a species-specific manner 111,112 .”
BackgroundThe microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic
Tan, A. H., Lim, S. Y., & Lang, A. E. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00681-2 · Cited by 392
Vinarov, Z., Abdallah, M., Agundez, J. A. G., Allegaert, K., Basit, A. W., Braeckmans, M., Ceulemans, J., Corsetti, M., Griffin, B. T., Grimm, M., et al. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105812 · Cited by 359
Metadata
- Authors
- Javdan, B., Lopez, J. G., Chankhamjon, P., Lee, Y.-C. J., Hull, R., Wu, Q., Wang, X., Chatterjee, S., & Donia, M. S.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 181
- Issue
- 7
- Pages
- 1661-1679.e22
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W3034548692
- Cited by
- 474
- References
- 88
- FWCI
- 14.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.